Joshua Adam Barocas, MD

Assistant Professor, Medicine

Joshua Barocas
617.414.2802

Biography

Joshua A. Barocas, MD is an Assistant Professor of Medicine at the Boston University School of Medicine. Before arriving at Boston University, Dr. Barocas was an Instructor at Harvard Medical School. He also completed a program in clinical effectiveness at the school of public health. Additionally, Dr. Barocas is an attending physician at the West Roxbury Veterans Administration Hospital and regularly leads case study discussions and conferences for medical students.

Education

  • George Washington University School of Medicine, MD
  • Washington University in St. Louis, BA

Publications

  • Published on 5/10/2019

    Barocas JA, Morgan JR, Fiellin DA, Schackman BR, Eftekhari Yazdi G, Stein MD, Freedberg KA, Linas BP. Cost-effectiveness of integrating buprenorphine-naloxone treatment for opioid use disorder into clinical care for persons with HIV/hepatitis C co-infection who inject opioids. Int J Drug Policy. 2019 May 10. PMID: 31085063.

    Read at: PubMed
  • Published on 5/8/2019

    Barocas JA, Wang J, Marshall BDL, LaRochelle MR, Bettano A, Bernson D, Beckwith CG, Linas BP, Walley AY. Sociodemographic factors and social determinants associated with toxicology confirmed polysubstance opioid-related deaths. Drug Alcohol Depend. 2019 May 08; 200:59-63. PMID: 31100636.

    Read at: PubMed
  • Published on 4/2/2019

    Barocas JA. Actions to Integrate Treatment of Opioid and Infectious Disease Epidemics. Ann Intern Med. 2019 Apr 02; 170(7):509. PMID: 30934073.

    Read at: PubMed
  • Published on 12/18/2018

    Barocas JA, Saitz R. Being Explicit About Decisions: Prescribe Medications for Opioid Use Disorder on the Basis of Proven Effectiveness, Not Beliefs. Ann Intern Med. 2018 Dec 18. PMID: 30557444.

    Read at: PubMed
  • Published on 10/25/2018

    Barocas JA, White LF, Wang J, Walley AY, LaRochelle MR, Bernson D, Land T, Morgan JR, Samet JH, Linas BP. Estimated Prevalence of Opioid Use Disorder in Massachusetts, 2011-2015: A Capture-Recapture Analysis. Am J Public Health. 2018 Dec; 108(12):1675-1681. PMID: 30359112.

    Read at: PubMed
  • Published on 8/1/2018

    Barocas JA, Tasillo A, Eftekhari Yazdi G, Wang J, Vellozzi C, Hariri S, Isenhour C, Randall L, Ward JW, Mermin J, Salomon JA, Linas BP. Population-level Outcomes and Cost-Effectiveness of Expanding the Recommendation for Age-based Hepatitis C Testing in the United States. Clin Infect Dis. 2018 Aug 01; 67(4):549-556. PMID: 29420742.

    Read at: PubMed
  • Published on 12/1/2017

    Barocas JA, Wang J, White LF, Tasillo A, Salomon JA, Freedberg KA, Linas BP. Hepatitis C Testing Increased Among Baby Boomers Following The 2012 Change To CDC Testing Recommendations. Health Aff (Millwood). 2017 Dec; 36(12):2142-2150. PMID: 29200354.

    Read at: PubMed
  • Published on 6/1/2017

    Barocas JA, Beiser M, León C, Gaeta JM, O'Connell JJ, Linas BP. Experience and Outcomes of Hepatitis C Treatment in a Cohort of Homeless and Marginally Housed Adults. JAMA Intern Med. 2017 06 01; 177(6):880-882. PMID: 28395004.

    Read at: PubMed
  • Published on 11/3/2016

    Barocas JA, Linas BP. Editorial Commentary: Decision Science at Work: The Case of Hepatitis C Virus Postexposure Prophylaxis. Clin Infect Dis. 2017 01 01; 64(1):100-101. PMID: 27815292.

    Read at: PubMed
  • Published on 4/6/2016

    Barocas JA, Linas BP, Kim AY, Fangman J, Westergaard RP. Acceptability of Rapid Point-of-Care Hepatitis C Tests Among People Who Inject Drugs and Utilize Syringe-Exchange Programs. Open Forum Infect Dis. 2016 Mar; 3(2):ofw075. PMID: 27191007.

    Read at: PubMed

View 12 more publications: View full profile at BUMC

View all profiles